HLA in multiple sclerosis. Relationship to measles antibody, mitogen responsiveness and clinical course. 1977

D W Paty, and J B Dossetor, and C R Stiller, and H K Cousin, and L Marchuk, and J Furesz, and D W Boucher

In our study of multiple sclerosis (MS) patients we have found significant increases in the A3, B7, and DW2 antigens. We have also studied immune responses in these same patients. There was elevation of measles antibodies in MS patients positive for A3, B7, and B18 as compared to MS patients without those antigens. The first study of mitogen responsiveness (31 patients) showed a decreased response in A3, and B7 positive patients. Study of a second and a larger group (62 patients), at a different time, failed to confirm this deficiency. We propose that there is a genetically linked (HLA) T cell deficiency in some MS patients and that this deficiency results in high humoral responses to measles antigens and an evanescent (or cyclical) reduced T cell response to mitogen.

UI MeSH Term Description Entries
D008459 Measles virus The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children. Edmonston virus
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006649 Histocompatibility Antigens A group of antigens that includes both the major and minor histocompatibility antigens. The former are genetically determined by the major histocompatibility complex. They determine tissue type for transplantation and cause allograft rejections. The latter are systems of allelic alloantigens that can cause weak transplant rejection. Transplantation Antigens,Antigens, Transplantation,Histocompatibility Antigen,LD Antigens,SD Antigens,Antigen, Histocompatibility,Antigens, Histocompatibility,Antigens, LD,Antigens, SD
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

D W Paty, and J B Dossetor, and C R Stiller, and H K Cousin, and L Marchuk, and J Furesz, and D W Boucher
March 1977, Transplantation proceedings,
D W Paty, and J B Dossetor, and C R Stiller, and H K Cousin, and L Marchuk, and J Furesz, and D W Boucher
April 1977, Acta neurologica Scandinavica,
D W Paty, and J B Dossetor, and C R Stiller, and H K Cousin, and L Marchuk, and J Furesz, and D W Boucher
September 1981, Neurology,
D W Paty, and J B Dossetor, and C R Stiller, and H K Cousin, and L Marchuk, and J Furesz, and D W Boucher
June 1976, Neurology,
D W Paty, and J B Dossetor, and C R Stiller, and H K Cousin, and L Marchuk, and J Furesz, and D W Boucher
April 1964, Archives of neurology,
D W Paty, and J B Dossetor, and C R Stiller, and H K Cousin, and L Marchuk, and J Furesz, and D W Boucher
November 1983, Annals of neurology,
D W Paty, and J B Dossetor, and C R Stiller, and H K Cousin, and L Marchuk, and J Furesz, and D W Boucher
April 1979, Clinical and experimental immunology,
D W Paty, and J B Dossetor, and C R Stiller, and H K Cousin, and L Marchuk, and J Furesz, and D W Boucher
March 1970, JAMA,
D W Paty, and J B Dossetor, and C R Stiller, and H K Cousin, and L Marchuk, and J Furesz, and D W Boucher
March 1990, Neurology,
D W Paty, and J B Dossetor, and C R Stiller, and H K Cousin, and L Marchuk, and J Furesz, and D W Boucher
July 2009, Tissue antigens,
Copied contents to your clipboard!